Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

Phase 3TerminatedNCT00560924

Novo Nordisk A/S6 enrolled

Overview

This trial is conducted in Europe. The aim of this trial is to investigate the preventive effect of treatment with estradiol vaginal tablets on recurrent urinary tract infections (RUTI) in post-menopausal women with signs of urogenital ageing (UGA).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Menopause Urinary Infections

Interventions

estradiol, 25 mcgDRUG

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Post-menopausal woman with Urogenital ageing (UGA) * Recurrent urinary tract infections defined as three or more urinary tract infections within the past twelve months Exclusion Criteria: * Known or suspected allergy to trial product or related products * Present UTI * History of RUTI during fertile period of life

Locations (1)

Novo Nordisk Investigational Site

Malmo, Sweden

Outcomes

Primary Outcomes

Time to first symptom of urinary tract infection (UTI)

Secondary Outcomes

Number of urinary tract infection (UTI)

Time frame: During the 12 months of treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.